Newsroom

CellCarta Adds Tempus to CDx Commercialization Lab Network

August 6, 2026

Categories: Biotechnology, Drug Discovery & Development, Pharma, Clinical Research & Trials

ARScience Biotherapeutics Initiates Technology Transfer for Commercial Manufacturing of Low Dose Interleukin-2

July 22, 2026

Categories: Healthcare, Clinical Research & Trials

Trajan expands US availability of Harpera™ Microbiopsy Punch for clinical skin sampling

July 20, 2026

Categories: biopharma, Digital Pathology, AI

CellCarta Launches Digital Pathology and AI Consortium to Accelerate Platform-Agnostic Biomarker Innovation Across Drug Development

July 15, 2026

Categories: Corporate, Finance & Investor, Medical Devices & Technology, Life Science

Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Engineering, Cybersecurity and AI

July 6, 2026

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, biopharma

Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomics to Compound Screening Scale

June 16, 2026

Categories: Biomanufacturing, Corporate, Finance & Investor

Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer

June 16, 2026

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

Alithea Genomics and Revvity announce distribution agreement to expand access to MERCURIUS™ DRUG-seq solutions

June 8, 2026

Categories: Corporate, Finance & Investor, Clinical Diagnostics, biopharma

Leica Biosystems and CellCarta expand collaborative companion diagnostic development model to accelerate commercialization globally

June 1, 2026